Familial adult myoclonus epilepsy: a pragmatic approach.
Ajith CherianKalikavil Puthanveedu DivyaA R Swathy KrishnanPublished in: Acta neurologica Belgica (2023)
Familial Adult Myoclonus Epilepsy (FAME), with a prevalence of < 1/35 000, is known under different acronyms. The disease is transmitted in an autosomal dominant manner and is characterized by the occurrence of cortical myoclonic tremor, overt myoclonus, and rare bilateral tonic-clonic seizures. FAME is considered neurodegenerative, although it is relatively slow in progression. Diagnosis is based on specific neurophysiological testing, namely jerk-locked back-averaging, somatosensory evoked potentials, long latency reflex, and motor evoked potentials, among others. Imaging data, including functional magnetic resonance imaging, indicate a cortical origin of the cortical myoclonic tremor and decreased cerebellar activation. Cerebellar changes in Purkinje cells have been noted, from few neuropathology reports, in patients from isolated pedigrees. The differential diagnosis includes essential tremor, some forms of genetic generalized epilepsy, and progressive myoclonus epilepsies. Treatment is mainly symptomatic.
Keyphrases
- deep brain stimulation
- magnetic resonance imaging
- parkinson disease
- end stage renal disease
- induced apoptosis
- ejection fraction
- early onset
- chronic kidney disease
- newly diagnosed
- high resolution
- risk assessment
- risk factors
- prognostic factors
- peritoneal dialysis
- oxidative stress
- emergency department
- patient reported outcomes
- gene expression
- big data
- contrast enhanced
- machine learning
- photodynamic therapy
- cell proliferation
- young adults
- combination therapy
- case report
- replacement therapy
- transcranial direct current stimulation
- artificial intelligence
- working memory